指南与共识甲状腺与颈部外科

重新评估甲状腺乳头状癌手术指南对生存的影响:扩大腺叶切除指征

Reassessing surgical guidelines for papillary thyroid cancer impact on survival: Expanding indications for lobectomy.
指南 / 共识 · Surgery · 2023-06-30

该回顾性队列研究纳入2004至2017年美国国家癌症数据库84,300例接受腺叶切除或全甲状腺切除的甲状腺乳头状癌患者,采用倾向性评分逆概率加权和灵活参数生存模型比较总生存,并定量评估未测量混杂的偏倚。结果显示两种术式在总生存及5年、10年生存上无统计学显著差异,各亚组(肿瘤大小、年龄、死亡风险)亦无显著差异,敏感性分析提示未测量混杂需极大效应才能改变主要发现。

要点

  • 腺叶切除与全甲状腺切除在甲状腺乳头状癌患者的总生存及5年、10年生存上无统计学显著差异。
  • 肿瘤大小<4 cm或≥4 cm、年龄<65或≥65岁及估计死亡风险亚组间生存均无统计学显著差异。
  • 未测量混杂需极大效应才能改变主要发现,提示全甲状腺切除较腺叶切除 unlikely 提供生存优势。

核心结论

  • 全甲状腺切除相比腺叶切除 unlikely 提供生存优势,无论肿瘤大小、患者年龄或总体死亡风险如何。

研究设计与样本

  • 回顾性队列研究,纳入2004至2017年美国国家癌症数据库84,300例接受腺叶切除或全甲状腺切除的甲状腺乳头状癌患者。
  • 采用灵活参数生存模型和倾向性评分逆概率加权评估总生存,并用双向确定性敏感性分析和两阶段最小二乘回归评估未观测混杂偏倚。

主要发现

  • 治疗患者中位年龄48岁(四分位距37-59),78%为女性,76%为白人。
  • 腺叶切除与全甲状腺切除患者的总生存及5年、10年生存无统计学显著差异。
  • 按肿瘤大小(<4 cm或≥4 cm)、年龄(<65或≥65岁)或估计死亡风险分亚组,生存均无统计学显著差异。
  • 敏感性分析提示,未测量混杂因素需具有极大效应才能改变主要发现。

临床怎么用

  • 对于甲状腺乳头状癌,腺叶切除可作为全甲状腺切除的合理替代,无需因肿瘤大小、年龄或总体死亡风险而常规扩大切除范围。

局限性

  • 研究为回顾性观察性设计,虽采用倾向性评分加权和敏感性分析,仍可能存在未测量混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Comparisons of lobectomy versus total thyroidectomy for papillary thyroid cancer have not addressed significant threats to valid inference from observational data. The purpose of this study was to compare survival after lobectomy versus total thyroidectomy for papillary thyroid cancer while addressing bias from unmeasured confounding. METHODS: This retrospective cohort study included 84,300 patients treated with lobectomy or total thyroidectomy for papillary thyroid cancer in the National Cancer Database from 2004 to 2017. The primary outcome was overall survival evaluated by flexible parametric survival models and inverse probability weighting on the propensity score. Bias from unobserved confounding was assessed using two-way deterministic sensitivity analysis and 2-stage least squares regression. RESULTS: The median age of treated patients was 48 years (interquartile range, 37-59), 78% were women, and 76% were white. We found no statistically significant differences in overall survival or 5- and 10-year survival between patients treated with lobectomy or total thyroidectomy. Additionally, we found no statistically significant difference in survival by subgroups, including tumor size (<4 cm or ≥4 cm), age (<65 or ≥65), or estimated risk of mortality. Sensitivity analyses suggested that an unmeasured confounder would need to have an extremely large effect to change the primary finding. CONCLUSION: This is the first study to compare lobectomy and total thyroidectomy outcomes while adjusting for and quantifying the potential effects of unmeasured confounding variables on observational data. The findings suggest that total thyroidectomy is unlikely to offer a survival advantage over lobectomy regardless of tumor size, patient age, or overall risk of death.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Stevens A, Meier J, Bhat A, et al. Reassessing surgical guidelines for papillary thyroid cancer impact on survival: Expanding indications for lobectomy. Surgery. 2023. PMID: 37393154. doi:10.1016/j.surg.2023.05.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。